Hubei Guangji Pharmaceutical's stock price decline and deter...
Hubei Guangji Pharmaceutical's stock price decline and deteriorating returns over the past year are disappointing. The company's situation echoes Warren Buffett's words, 'turnarounds seldom turn'. The falling EPS and share price indicate a tough outlook.
Shareholders in Hubei Guangji Pharmaceutical (SZSE:000952) Have Lost 15%, as Stock Drops 14% This Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment